Ana Sayfa
Piyasalar
Grafikler ve Fikirler
Algo
Haberler
Store
Aracı Kurumlar
İndir
Ekonomik Takvim
Alım-Satım Sinyalleri
Web Terminali
Heatmap
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
TXG
#1647
10x Genomics, Inc. Class A Common Stock
24.800
0
USD
+5.17%
Sektör:
Sağlık Hizmetleri
Baz:
USD
Kar Para Birimi:
USD
Günlük Aralık
Yıllık Aralık
Günlük Değişim
+5.17%
Aylık Değişim
+29.71%
6 aylık değişim
+79.45%
Yıllık Değişim
+79.45%
Önceki Kapanış
23.580
0
Open
24.800
0
Bid
Ask
Low
24.800
0
High
24.800
0
Hacim
195
Piyasalar
ABD Borsası
Sağlık Hizmetleri
TXG
Open full chart
Financials
Overview
Rapor
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
108.75 M
112.84 M
115.36 M
119.17 M
122.3 M
127.75 M
—
Valuation ratios
Enterprise value
14.8 B
16.22 B
3.86 B
6.11 B
1.41 B
1.61 B
4.4 B
Price to earnings ratio
—
-281.06
-24.2
-24.91
-9.45
-46.6
-88.71
Price to sales ratio
—
33.51
7.79
10.28
2.83
3.17
9.29
Price to cash flow ratio
—
-769.07
-119.7
-418.64
259.56
14.96
71.37
Price to book ratio
—
20.11
4.99
8.59
2.44
2.56
3.89
Enterprise value to EBITDA ratio
-28.33
-521.02
-27.04
-26.59
-8.9
-64.94
-104.16
Profitability ratios
Return on assets %
-0.58
-0.06
-0.16
-0.26
-0.2
-0.04
-0.05
Return on equity %
-0.73
-0.07
-0.21
-0.34
-0.26
-0.05
-0.06
Return on invested capital %
-1 096.79
-75.34
-154.45
-210.69
-166.94
-59.57
-56.72
Gross margin %
80.44
84.89
76.69
66.15
67.86
69.05
275.83
Operating margin %
-178.74
-10.65
-32.52
-42.88
-31.85
-9.49
-41.38
EBITDA margin %
-174.05
-6.35
-27.61
-37.14
-25.98
-3.86
-18.71
Net margin %
-181.61
-11.87
-32.15
-41.23
-29.9
-6.77
-30.43
Liquidity ratios
Quick ratio
6.3
6.23
4.23
4.11
4.26
4.09
18.06
Current ratio
6.56
6.77
4.85
4.69
4.97
4.46
20.15
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.39
0.5
0.5
0.62
0.65
0.66
0.66
Solvency ratios
Debt to assets ratio
0.07
—
—
—
—
—
—
Debt to equity ratio
0.09
—
—
—
—
—
—
Long term debt to total assets ratio
0
—
—
—
—
—
—
Long term debt to total equity ratio
0
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
-0.19
-0.3
-0.13
0.06
1.09
1.09
EBIT per share
—
-0.47
-1.48
-2.26
-1.62
-0.49
-0.49
EBITDA per share
—
-0.28
-1.25
-1.96
-1.32
-0.2
-0.2
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
5.32
3.78
3.32
3.27
4.2
15.11
Net current asset value per share
—
6.77
5.58
5.09
4.85
5.49
20.74
Tangible book value per share
—
7.14
6.84
6.14
5.73
5.85
23.21
Working capital per share
—
5.77
4.43
4
3.88
4.26
16.55
Book value per share
—
7.41
7.08
6.32
5.9
6.38
24.62
10x Genomics Inc
10x Genomics, Inc. is an American biotechnology company that designs and manufactures sequencing technologies for use in scientific research, with a focus on product development for single-cell and spatial omics.
Haberler
Stock Picks From Seeking Alpha's March 2026 New Analysts
10x Genomics hissesi 23,6 dolarda 52 haftalık zirve yaptı
Canada stocks higher at close of trade; S&P/TSX Composite up 0.58%
William Blair, 10X Genomics hissesi için tavsiyesini yükseltti
Tempus AI Reinforces Market Position With Collaborations in 2026
Bioptimus, 10x Genomics ile uzamsal biyoloji atlası başlattı
Cathie Wood’un ARK’ı Twist Bioscience sattı, Circle aldı
10x Genomics: Undervalued Amid Consumables-Led Transition (NASDAQ:TXG)
Cathie Wood’un ARK’ı Bullish hissesi sattı, 10X Genomics aldı
Tempus AI's Diagnostics and Data Arms Drive Long-Term Growth Story
Cathie Wood’un ARK’ı Circle Internet hissesi sattı, Figma aldı
Microsoft’un yapay zeka modeli spatialomics hisselerinde satışa yol açtı